Keywords: Actelion, 2012 financial results

Actelion posts strong earnings growth but flat sales for 2012

Article | 14 February 2013

Switzerland-based Actelion (SIX: ATLN), Europe’s largest biotechnology firm, this morning reported 2012 financial results, with a 1% (-2% local currency) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Actelion

Go to company listing